/
RSS Feed
With global pharma experiencing increasing levels of reorganization and M&A activity, our second installment of the Spotlight on Japan mini-series, with Mihoko Ida, a corporate partner based in Baker McKenzie’s Tokyo office and Mami Ohara, a member of the Healthcare & Life Sciences Group with experience in corporate reorganizations, takes a closer look at the regulatory landscape of the Japanese pharmaceutical industry, including regulatory license frameworks, high-level implications of licensing in M&A transactions and other regulatory considerations.
